KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,007,953 | +3.7% | 104,668 | -3.1% | 0.01% | 0.0% |
| Q2 2023 | $971,775 | +23.8% | 107,975 | +8.1% | 0.01% | +25.0% |
| Q1 2023 | $784,986 | +24.3% | 99,871 | +6.9% | 0.00% | 0.0% |
| Q4 2022 | $631,472 | -54.5% | 93,413 | -2.3% | 0.00% | -55.6% |
| Q3 2022 | $1,387,000 | +114.0% | 95,586 | +45.1% | 0.01% | +125.0% |
| Q2 2022 | $648,000 | +92.3% | 65,882 | +187.8% | 0.00% | +100.0% |
| Q1 2022 | $337,000 | +59.0% | 22,893 | +42.7% | 0.00% | +100.0% |
| Q4 2021 | $212,000 | +2.4% | 16,048 | +35.0% | 0.00% | 0.0% |
| Q3 2021 | $207,000 | – | 11,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |